- Abstract:
-
BACKGROUND: Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true disease-modifying effects. A systematic review was undertaken to determine what biomarkers for disease progression in Parkinson's disease (PD) exist. METHODS: MEDLINE and EMBASE (1950-2010) were searched using five search strategies. Abstracts were assessed to identify papers meriting review in ...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's version
- Files:
-
-
(zip, 602.5KB)
-
(bin, 169.5KB)
-
(pdf, 346.6KB)
-
- Publisher copy:
- 10.1186/1471-2377-13-35
- Publisher:
- BioMed Central Ltd. Publisher's website
- Journal:
- BMC Neurology Journal website
- Volume:
- 13
- Issue:
- 1
- Pages:
- Article: 35
- Publication date:
- 2013-01-01
- DOI:
- EISSN:
-
1471-2377
- ISSN:
-
1471-2377
- URN:
-
uuid:9b5a5e99-5dc5-48c0-a24a-3044df6f66fe
- Source identifiers:
-
457553
- Local pid:
- pubs:457553
- Language:
- English
- Keywords:
- Subjects:
- Copyright holder:
- McGhee et al.
- Copyright date:
- 2013
- Notes:
- © 2013 McGhee et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Journal article
A systematic review of biomarkers for disease progression in Parkinson's disease.
Actions
Access Document
Authors
Funding
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record